Advertisement

Topics

Malin Investee Company – Melinta Therapeutics – To Be Transformed into a NASDAQ Listed Company

09:00 EDT 9 Aug 2017 | Biotech 365

Melinta is Malin’s second largest investment by capital committed Definitive agreement entered into with Cempra, Inc. Expected positive returns driven by the value of the combined equity over time Combined company will be called Melinta Therapeutics Company will be a … Continue reading

Cet article Malin Investee Company – Melinta Therapeutics – To Be Transformed into a NASDAQ Listed Company est apparu en premier sur Biotech 365.

Original Article: Malin Investee Company – Melinta Therapeutics – To Be Transformed into a NASDAQ Listed Company

NEXT ARTICLE

More From BioPortfolio on "Malin Investee Company – Melinta Therapeutics – To Be Transformed into a NASDAQ Listed Company"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...